Santhera Pharmaceuticals Statements
SA
Santhera Pharmaceuticals Income Statement
B
M
CHF (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
99.475
100
1.307
1.3
98.168
98.7
8.926
9
18.358
18.5
26.702
26.8
71.466
71.8
-10.909
-11
—
0
78.24
78.7
0.122
0.1
78.118
78.5
7.1
11.003
3.939
100
1.928
48.9
2.011
51.1
9.748
247.5
12.608
320.1
22.316
566.5
-20.305
-515.5
-2.759
-70.04
-0.102
-2.6
-23.42
-594.6
-0.084
-2.1
-23.336
-592.4
-20.91
1.116
1.223
100
1.717
140.4
-0.494
-40.4
13.666
1117.4
12.372
1011.6
25.946
2121.5
-26.44
-2161.9
-17.017
-1391.4
1.973
161.3
-41.484
-3392
-0.132
-10.8
-41.352
-3381.2
-6.349
6.513
6.25
100
1.875
30
4.375
70
16.87
269.9
13.05
208.8
29.911
478.6
-25.536
-408.6
-3.591
-57.5
-0.005
-0.08
-29.132
-466.1
0.592
9.5
-29.724
-475.6
-5.24
5.672
-6.087
100
1.736
-28.5
-7.823
128.5
16.123
-264.9
13.742
-225.8
29.646
-487.04
-37.469
615.6
2.832
-46.5
-0.272
4.5
-34.909
573.5
0.156
-2.6
-35.065
576.1
-7.607
4.61
4.492
100
2.031
45.2
2.461
54.8
13.592
302.6
8.315
185.1
21.938
488.4
-19.477
-433.6
-10.661
-237.3
10.272
228.7
-19.866
-442.3
0.653
14.5
-20.519
-456.8
-0.922
22.244
7.233
100
8.317
115
-1.084
-15
16.54
228.7
9.939
137.4
26.099
360.8
-27.183
-375.8
-1.328
-18.4
-7.479
-103.4
-35.99
-497.6
-0.158
-2.2
-35.832
-495.4
-2.36
15.183
7.775
100
2.114
27.2
5.661
72.8
17.688
227.5
13.975
179.7
31.554
405.8
-25.893
-333.03
-4.796
-61.7
-0.777
-10
-31.466
-404.7
0.361
4.6
-31.827
-409.4
-2.78
11.449
57.061
100
2.893
5.1
54.168
94.9
21.919
38.4
20.463
35.9
42.176
73.9
11.992
21
-3.887
-6.8
—
0
8.105
14.2
0.178
0.3
7.927
13.9
0.715
11.092
7.607
100
1.165
15.3
6.442
84.7
8.244
108.4
8.957
117.7
17.312
227.6
-10.87
-142.9
-1.415
-18.6
—
0
-12.285
-161.5
0.287
3.8
-12.572
-165.3
-1.94
6.48